• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intrahepatic cholangiocarcinoma: management options and emerging therapies.

作者信息

Dodson Rebecca M, Weiss Matthew J, Cosgrove David, Herman Joseph M, Kamel Ihab, Anders Robert, Geschwind Jean-Francois H, Pawlik Timothy M

机构信息

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

J Am Coll Surg. 2013 Oct;217(4):736-750.e4. doi: 10.1016/j.jamcollsurg.2013.05.021. Epub 2013 Jul 24.

DOI:10.1016/j.jamcollsurg.2013.05.021
PMID:23890842
Abstract
摘要

相似文献

1
Intrahepatic cholangiocarcinoma: management options and emerging therapies.肝内胆管癌：治疗选择与新兴疗法
J Am Coll Surg. 2013 Oct;217(4):736-750.e4. doi: 10.1016/j.jamcollsurg.2013.05.021. Epub 2013 Jul 24.
2
Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.肝内胆管癌及肝细胞-胆管细胞癌合并症：西方经验
Ann Surg Oncol. 2008 Jul;15(7):1880-90. doi: 10.1245/s10434-008-9933-y. Epub 2008 Apr 29.
3
Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.比较肝细胞癌-胆管细胞癌与其他原发性肝癌的临床特征。
J Gastroenterol Hepatol. 2013 Jan;28(1):122-7. doi: 10.1111/j.1440-1746.2012.07289.x.
4
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.肝细胞癌合并胆管细胞癌：临床特征、治疗方式和预后。
Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.
5
Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.原发性硬化性胆管炎患者肝胆癌的危险因素及临床表现：一项病例对照研究。
Hepatology. 1998 Feb;27(2):311-6. doi: 10.1002/hep.510270201.
6
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.肝细胞癌和肝内胆管癌的流行病学
Cancer Control. 2017 Jul-Sep;24(3):1073274817729245. doi: 10.1177/1073274817729245.
7
Intrahepatic cholangiocarcinoma: new insights in pathology.肝内胆管细胞癌：病理学新见解。
Semin Liver Dis. 2011 Feb;31(1):49-60. doi: 10.1055/s-0031-1272839. Epub 2011 Feb 22.
8
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.乙型肝炎病毒相关的肝内胆管细胞癌和肝细胞癌可能具有共同的致癌过程。
Eur J Cancer. 2010 Apr;46(6):1056-61. doi: 10.1016/j.ejca.2010.02.005. Epub 2010 Mar 4.
9
Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours.乙型肝炎病毒感染患者肝内胆管癌的特征：切除肿瘤的临床病理研究。
J Viral Hepat. 2013 May;20(5):306-10. doi: 10.1111/jvh.12005. Epub 2012 Sep 13.
10
[Primary sclerosing cholangitis].[原发性硬化性胆管炎]
Ned Tijdschr Geneeskd. 2010;154:A1476.

引用本文的文献

1
The multi-kingdom cancer microbiome.多界癌症微生物组
Nat Microbiol. 2025 Sep 9. doi: 10.1038/s41564-025-02103-7.
2
LR-M for CT/MRI on LI-RADS v2018: a review of imaging criteria, performance, challenges and future directions from an end-user perspective.基于LI-RADS v2018的CT/MRI肝脏报告和数据系统：从终端用户角度对成像标准、性能、挑战及未来方向的综述
Abdom Radiol (NY). 2025 Aug 14. doi: 10.1007/s00261-025-05132-2.
3
Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts.
超声监测改善胆管癌生存结局：多中心回顾性队列研究
Heliyon. 2024 Sep 20;10(18):e38191. doi: 10.1016/j.heliyon.2024.e38191. eCollection 2024 Sep 30.
4
Exploratory Analyses of Circulating Neoplastic-Immune Hybrid Cells as Prognostic Biomarkers in Advanced Intrahepatic Cholangiocarcinoma.循环肿瘤-免疫杂交细胞作为晚期肝内胆管癌预后生物标志物的探索性分析。
Int J Mol Sci. 2024 Aug 24;25(17):9198. doi: 10.3390/ijms25179198.
5
Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches.通过组学和多组学方法揭示肝内胆管癌的异质性
Cancers (Basel). 2024 Aug 20;16(16):2889. doi: 10.3390/cancers16162889.
6
Management of Localized Intrahepatic Cholangiocarcinoma: What Exactly is the 'Evidence'?局限性肝内胆管癌的管理：究竟什么才是“证据”？
Ann Surg Oncol. 2024 Nov;31(12):7676-7678. doi: 10.1245/s10434-024-16023-z. Epub 2024 Aug 5.
7
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation.胆管癌：包括肝移植在内的手术选择现状
Cancers (Basel). 2024 May 21;16(11):1946. doi: 10.3390/cancers16111946.
8
Serum high-density lipoprotein cholesterol levels predict early recurrence and prognosis of intrahepatic cholangiocarcinoma after surgical resection.血清高密度脂蛋白胆固醇水平可预测肝内胆管癌手术切除后的早期复发及预后。
Heliyon. 2024 May 29;10(11):e32113. doi: 10.1016/j.heliyon.2024.e32113. eCollection 2024 Jun 15.
9
Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications.通过病理和分子分类在胆道癌诊断方面的最新进展
Cancers (Basel). 2024 May 1;16(9):1761. doi: 10.3390/cancers16091761.
10
An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy.一位晚期肝内胆管细胞癌患者从个体化免疫治疗中获益。
Inflammation. 2024 Oct;47(5):1699-1705. doi: 10.1007/s10753-024-02003-8. Epub 2024 Mar 16.